Skip to content

Insider · CIK 0001033876

MEISTER PAUL M

Reports to the SEC for 16 companies · SCHAFFHAUSEN

Transactions

50

Companies

16

Filings

12

CIK

0001033876

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-09-18VGNTVersigent PLC · Dividend Equivalent RightsA Award—
2026-08-05APTVAptiv PLCP Purchase+$5M
2026-05-07AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2026-05-07AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion—
2026-05-06AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2026-04-29APTVAptiv PLCA Award—
2026-04-28APTVAptiv PLCF Tax Payment−$34.9K
2026-04-22VGNTVersigent PLCA Award—
2026-01-02QTRXQuanterix CorpA Award—
2025-07-01QTRXQuanterix CorpA Award+$15K
2025-05-14APTVAptiv PLCG Gift—
2025-05-06AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2025-05-05AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2025-05-05AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion—
2025-04-23APTVAptiv PLCA Award—
2025-04-22APTVAptiv PLCF Tax Payment−$12.1K
2025-04-01QTRXQuanterix CorpA Award+$16.5K
2025-01-02QTRXQuanterix CorpA Award—
2025-01-02QTRXQuanterix CorpA Award+$15K
2025-01-02QTRXQuanterix Corp · Stock Options (Right to buy)A Award—
2024-10-01QTRXQuanterix CorpA Award+$15K
2024-07-01QTRXQuanterix CorpA Award+$15K
2024-05-10AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2024-05-10AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion—
2024-05-02AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2024-04-25APTVAptiv PLCA Award—
2024-04-23APTVAptiv PLCF Tax Payment−$23.7K
2024-04-01QTRXQuanterix CorpA Award+$15K
2024-01-02QTRXQuanterix CorpA Award—
2024-01-02QTRXQuanterix CorpA Award+$15K
2024-01-02QTRXQuanterix Corp · Stock Option (Right to Buy)A Award—
2023-10-02QTRXQuanterix CorpA Award+$15K
2023-07-03QTRXQuanterix CorpA Award+$15K
2023-06-07QTRXQuanterix CorpM Exercise/Conversion+$67.4K
2023-06-07QTRXQuanterix Corp · Stock Options (Right to buy)M Exercise/Conversion—
2023-06-06Telesis Bio Inc.A Award—
2023-06-06Telesis Bio Inc.Stock Option (Right to Buy)A Award—
2023-05-10AMRXAmneal Pharmaceuticals, Inc.M Exercise/Conversion—
2023-05-10AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion—
2023-05-09AMRXAmneal Pharmaceuticals, Inc. · Restricted Stock UnitsA Award—
2023-04-26APTVAptiv PLCA Award—
2023-04-25APTVAptiv PLCF Tax Payment−$40.3K
2023-04-03QTRXQuanterix CorpA Award+$15K
2023-01-03QTRXQuanterix Corp · Stock Option (Right to Buy)A Award—
2023-01-03QTRXQuanterix CorpA Award+$15K
2023-01-03QTRXQuanterix CorpA Award—
2022-10-03QTRXQuanterix CorpA Award+$15K
2022-08-10QTRXQuanterix CorpP Purchase+$1.59M
2022-08-10QTRXQuanterix CorpP Purchase+$413K
2022-07-01QTRXQuanterix CorpA Award+$15K